Search Results - "Weiner, Daniel E."

Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention by Drew, David A., Weiner, Daniel E., Sarnak, Mark J.

“…Patients with chronic kidney disease (CKD) are at substantially higher risk for developing cognitive impairment compared with the general population, and both…”
Get full text

KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) by Isakova, Tamara, Nickolas, Thomas L., Denburg, Michelle, Yarlagadda, Sri, Weiner, Daniel E., Gutiérrez, Orlando M., Bansal, Vinod, Rosas, Sylvia E., Nigwekar, Sagar, Yee, Jerry, Kramer, Holly

“…Chronic kidney disease–mineral and bone disorder (CKD-MBD) encompasses laboratory and bone abnormalities and vascular calcification and has deleterious effects…”
Get full text

COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider by Hsu, Caroline M., Weiner, Daniel E., Aweh, Gideon, Miskulin, Dana C., Manley, Harold J., Stewart, Carol, Ladik, Vlad, Hosford, John, Lacson, Edward C., Johnson, Douglas S., Lacson, Eduardo

“…During the coronavirus disease 2019 (COVID-19) pandemic, patients receiving maintenance dialysis are a highly vulnerable population due to their comorbidities…”
Get full text

Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation by Johnson, Richard J., Bakris, George L., Borghi, Claudio, Chonchol, Michel B., Feldman, David, Lanaspa, Miguel A., Merriman, Tony R., Moe, Orson W., Mount, David B., Sanchez Lozada, Laura Gabriella, Stahl, Eli, Weiner, Daniel E., Chertow, Glenn M.

“…Urate is a cause of gout, kidney stones, and acute kidney injury from tumor lysis syndrome, but its relationship to kidney disease, cardiovascular disease, and…”
Get full text

Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS) by Karaboyas, Angelo, MS, Zee, Jarcy, PhD, Brunelli, Steven M., MD, MSCE, Usvyat, Len A., PhD, Weiner, Daniel E., MD, MS, Maddux, Franklin W., MD, Nissenson, Allen R., MD, Jadoul, Michel, MD, Locatelli, Francesco, MD, FRCPC, Winkelmayer, Wolfgang C., MD, ScD, Port, Friedrich K., MD, MS, Robinson, Bruce M., MD, MS, Tentori, Francesca, MD, MS

“…Background Sudden death is a leading cause of death in patients on maintenance hemodialysis therapy. During hemodialysis sessions, the gradient between serum…”
Get full text

Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages by Dad, Taimur, MD, Weiner, Daniel E., MD, MS

“…Summary Cerebrovascular disease and stroke are very common at all stages of chronic kidney disease (CKD), likely representing both shared risk factors as well…”
Get full text

Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes by Berlowitz, Dan R, Foy, Capri G, Kazis, Lewis E, Bolin, Linda P, Conroy, Molly B, Fitzpatrick, Peter, Gure, Tanya R, Kimmel, Paul L, Kirchner, Kent, Morisky, Donald E, Newman, Jill, Olney, Christine, Oparil, Suzanne, Pajewski, Nicholas M, Powell, James, Ramsey, Thomas, Simmons, Debra L, Snyder, Joni, Supiano, Mark A, Weiner, Daniel E, Whittle, Jeff

“…A secondary analysis of SPRINT, a trial involving patients with hypertension and high cardiovascular risk in which intensive therapy resulted in lower rates of…”
Get full text

Immunogenicity of SARS-CoV-2 Vaccine in Dialysis by Lacson, Jr, Eduardo, Argyropoulos, Christos P, Manley, Harold J, Aweh, Gideon, Chin, Andrew I, Salman, Loay H, Hsu, Caroline M, Johnson, Doug S, Weiner, Daniel E

“…Patients receiving maintenance dialysis represent a high-risk, immune-compromised population with 15%-25% COVID-19 mortality rate who were unrepresented in…”
Get full text

Improving Clinical Outcomes Among Hemodialysis Patients: A Proposal for a “Volume First” Approach From the Chief Medical Officers of US Dialysis Providers by Weiner, Daniel E., MD, MS, Brunelli, Steven M., MD, MSCE, Hunt, Abigail, PhD, Schiller, Brigitte, MD, Glassock, Richard, MD, Maddux, Frank W., MD, Johnson, Douglas, MD, Parker, Tom, MD, Nissenson, Allen, MD

“…Addressing fluid intake and volume control requires alignment and coordination of patients, providers, dialysis facilities, and payers, potentially…”
Get full text

Evaluation of Screening Tests for Cognitive Impairment in Patients Receiving Maintenance Hemodialysis by Drew, David A, Tighiouart, Hocine, Rollins, Jasmine, Duncan, Sarah, Babroudi, Seda, Scott, Tammy, Weiner, Daniel E, Sarnak, Mark J

“…Neurocognitive testing shows that cognitive impairment is common among patients receiving maintenance hemodialysis. Identification of a well performing…”
Get full text

Cognitive Decline and Its Risk Factors in Prevalent Hemodialysis Patients by Drew, David A., MD, MS, Weiner, Daniel E., MD, MS, Tighiouart, Hocine, MS, Duncan, Sarah, BA, Gupta, Aditi, MD, Scott, Tammy, PhD, Sarnak, Mark J., MD, MS

“…Background Cognitive impairment is common in patients treated with hemodialysis. The trajectory of cognitive function and risk factors for cognitive decline…”
Get full text

Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months by Hsu, Caroline M, Weiner, Daniel E, Manley, Harold J, Aweh, Gideon N, Ladik, Vladimir, Frament, Jill, Miskulin, Dana, Argyropoulos, Christos, Abreo, Kenneth, Chin, Andrew, Gladish, Reginald, Salman, Loay, Johnson, Doug, Lacson, Jr, Eduardo K

“…Although most patients receiving maintenance dialysis exhibit initial seroresponse to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination,…”
Get full text

Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial by Charytan, David M, Himmelfarb, Jonathan, Ikizler, T Alp, Raj, Dominic S, Hsu, Jesse Y, Landis, J Richard, Anderson, Amanda H, Hung, Adriana M, Mehrotra, Rajnish, Sharma, Shailendra, Weiner, Daniel E, Williams, Mark, DiCarli, Marcelo, Skali, Hicham, Kimmel, Paul L, Kliger, Alan S, Dember, Laura M

“…The safety and efficacy of spironolactone is uncertain in end-stage renal disease. We randomized 129 maintenance hemodialysis patients to placebo (n=51) or…”
Get more information

Biomarkers of Kidney Injury Among Nicaraguan Sugarcane Workers by Laws, Rebecca L., PhD, MPH, Brooks, Daniel R., DSc, Amador, Juan José, MD, MPH, Weiner, Daniel E., MD, MS, Kaufman, James S., MD, Ramírez-Rubio, Oriana, MD, PhD, MPH, Riefkohl, Alejandro, MD, Scammell, Madeleine K., DSc, López-Pilarte, Damaris, MPH, Sánchez, José Marcel, Lic, Parikh, Chirag R., MD, PhD, McClean, Michael D., ScD

“…Background In Central America, an epidemic of chronic kidney disease of unknown cause disproportionately affects young male agricultural workers. Study Design…”
Get full text

Uric Acid and Incident Kidney Disease in the Community by WEINER, Daniel E, TIGHIOUART, Hocine, ELSAYED, Essam F, GRIFFITH, John L, SALEM, Deeb N, LEVEY, Andrew S

“…Uric acid may mediate aspects of the relationship between hypertension and kidney disease via renal vasoconstriction and systemic hypertension. To investigate…”
Get full text

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT) by Weiner, Daniel E., MD, MS, Gaussoin, Sarah A., MS, Nord, John, MD, MS, Auchus, Alexander P., MD, Chelune, Gordon J., PhD, Chonchol, Michel, MD, Coker, Laura, PhD, Haley, William E., MD, Killeen, Anthony A., MD, PhD, Kimmel, Paul L., MD, Lerner, Alan J., MD, Oparil, Suzanne, MD, Saklayen, Mohammad G., MBBS, Slinin, Yelena M., MD, MS, Wright, Clinton B., MD, MS, Williamson, Jeff D., MD, Kurella Tamura, Manjula, MD, MPH

“…Background Chronic kidney disease is common and is associated with cardiovascular disease, cerebrovascular disease, and cognitive function, although the nature…”
Get full text

Anatomic Brain Disease in Hemodialysis Patients: A Cross-sectional Study by Drew, David A., MD, Bhadelia, Rafeeque, MD, Tighiouart, Hocine, MS, Novak, Vera, MD, PhD, Scott, Tammy M., PhD, Lou, Kristina V., MS, MPH, Shaffi, Kamran, MD, Weiner, Daniel E., MD, MS, Sarnak, Mark J., MD, MS

“…Background Although dialysis patients are at high risk of stroke and have a high burden of cognitive impairment, there are few reports of anatomic brain…”
Get full text

Acute Kidney Injury in Sugarcane Workers at Risk for Mesoamerican Nephropathy by Kupferman, Joseph, Ramírez-Rubio, Oriana, Amador, Juan José, López-Pilarte, Damaris, Wilker, Elissa H., Laws, Rebecca L., Sennett, Caryn, Robles, Ninoska Violeta, Lau, Jorge Luis, Salinas, Alejandro José, Kaufman, James S., Weiner, Daniel E., Scammell, Madeleine K., McClean, Michael D., Brooks, Daniel R., Friedman, David J.

“…Mesoamerican nephropathy (MeN), a form of chronic kidney disease (CKD) of unknown cause in Central America, affects young individuals working in physically…”
Get full text

Frequency of and risk factors for poor cognitive performance in hemodialysis patients by SARNAK, Mark J, TIGHIOUART, Hocine, WEINER, Daniel E, SCOTT, Tammy M, LOU, Kristina V, SORENSEN, Eric P, GIANG, Lena M, DREW, David A, SHAFFI, Kamran, STROM, James A, SINGH, Ajay K

“…There are few detailed data on cognition in patients undergoing dialysis. We evaluated the frequency of and risk factors for poor cognitive performance using…”
Get full text

The Central American Epidemic of CKD by Weiner, Daniel E, McClean, Michael D, Kaufman, James S, Brooks, Daniel R

“…Recent reports have described an apparent epidemic of CKD along the Pacific coast of Central America, such that CKD is a leading cause of death among…”
Get full text